查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
感染疾病診斷市場報告：2030 年趨勢、預測與競爭分析
市場調查報告書
商品編碼
1416293

感染疾病診斷市場報告：2030 年趨勢、預測與競爭分析

Infectious Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

感染疾病診斷的趨勢和預測

到 2030 年，全球感染疾病診斷市場預計將達到 499 億美元，2024 年至 2030 年複合年成長率為 5.1%。該市場的主要促進因素是感染疾病病率的增加以及對疾病早期檢測的認知不斷提高。全球感染疾病診斷市場的未來前景廣闊，免疫診斷、NGS、INAAT 和 PCR 市場充滿機會。

感染疾病診斷市場洞察

Lucintel 預計，由於這些產品的重複使用，在整個預測期內，試劑、套件和消耗品將繼續成為最大的細分市場。

由於在 COVID-19感染疾病和 POC傳染病檢查等測試中擴大使用免疫測量，免疫診斷將繼續成為該市場的最大細分市場。

由於感染率高、醫療基礎設施完善以及該地區醫療支出不斷增加，北美在整個預測期內仍將是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球感染疾病診斷市場預計將達到 499 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球感染疾病診斷市場預計將以5.1%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要促進因素是感染疾病的日益普及和人們對疾病早期檢測的認知不斷提高。

Q4.市場的主要細分市場是：

A4.感染疾病診斷市場前景廣闊，免疫診斷、NGS、INAAT 和 PCR 市場充滿機會。

Q5.市場的主要企業是：

A5. 主要感染疾病診斷公司如下。

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於試劑、套件和消耗品的重複使用，在整個預測期內，這些產品將繼續成為最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於該地區的高感染率、完善的醫療基礎設施以及不斷上升的醫療成本，北美在整個預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球感染疾病診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球感染疾病診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 全球感染疾病診斷市場（按產品）
    • 試劑、套件及耗材
    • 裝置
    • 軟體和服務
  • 按測試類型分類的全球感染疾病診斷市場
    • 實驗室
    • POC
  • 按技術分類的全球感染疾病診斷市場
    • 免疫診斷
    • NGS
    • INAAT
    • PCR
  • 按最終用途分類的全球感染疾病診斷市場
    • 醫院
    • 實驗室

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球感染疾病診斷市場
  • 北美感染疾病診斷市場
  • 歐洲感染疾病診斷市場
  • 亞太感染疾病診斷市場
  • 其他地區感染疾病診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球感染疾病診斷市場成長機會（按產品）
    • 按測試類型分類的全球感染疾病診斷市場成長機會
    • 全球感染疾病診斷市場的技術成長機會
    • 按最終用途分類的全球感染疾病診斷市場的成長機會
    • 全球感染疾病診斷市場按地區成長機會
  • 全球感染疾病診斷市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球感染疾病診斷市場的能力
    • 全球感染疾病診斷市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson
簡介目錄

Infectious Disease Diagnostics Trends and Forecast

The future of the global infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets. The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

A more than 150-page report is developed to help in your business decisions.

Infectious Disease Diagnostics by Segment

The study includes a forecast for the global infectious disease diagnostics by product, test type, technology, end use, and region.

Infectious Disease Diagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents, Kits, and Consumables
  • Instruments
  • Software & Services

Infectious Disease Diagnostics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Lab
  • POC

Infectious Disease Diagnostics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Immunodiagnostics
  • NGS
  • INAAT
  • PCR

Infectious Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Labs

Infectious Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Infectious Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infectious disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infectious disease diagnostics companies profiled in this report include-

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Infectious Disease Diagnostics Market Insights

Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Within this market, immunodiagnostics will remain the largest segment due to increasing usage of immunoassays in COVID-19 testing, POC infectious disease testing, and others.

North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Features of the Global Infectious Disease Diagnostics Market

Market Size Estimates: Infectious disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Infectious disease diagnostics market size by various segments, such as by product, test type, technology, end use, and region in terms of value ($B).

Regional Analysis: Infectious disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, test types, technologies, end uses, and regions for the infectious disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infectious disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the infectious disease diagnostics market size?

Answer: The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030.

Q2. What is the growth forecast for infectious disease diagnostics market?

Answer: The global infectious disease diagnostics market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the infectious disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

Q4. What are the major segments for infectious disease diagnostics market?

Answer: The future of the infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets.

Q5. Who are the key infectious disease diagnostics market companies?

Answer: Some of the key infectious disease diagnostics companies are as follows:

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • bioMerieux
  • Siemens Healthineers
  • Danaher Corporation
  • Becton and Dickinson

Q6. Which infectious disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Q7. In infectious disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the infectious disease diagnostics market by product (reagents, kits, and consumables, instruments, and software & services), test type (lab and POC), technology (immunodiagnostics, NGS, INAAT, and PCR), end use (hospitals and labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Infectious Disease Diagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Infectious Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Infectious Disease Diagnostics Market by Product
    • 3.3.1: Reagents, Kits, and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software & Services
  • 3.4: Global Infectious Disease Diagnostics Market by Test Type
    • 3.4.1: Lab
    • 3.4.2: POC
  • 3.5: Global Infectious Disease Diagnostics Market by Technology
    • 3.5.1: Immunodiagnostics
    • 3.5.2: NGS
    • 3.5.3: INAAT
    • 3.5.4: PCR
  • 3.6: Global Infectious Disease Diagnostics Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Labs

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Infectious Disease Diagnostics Market by Region
  • 4.2: North American Infectious Disease Diagnostics Market
    • 4.2.2: North American Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
  • 4.3: European Infectious Disease Diagnostics Market
    • 4.3.1: European Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
    • 4.3.2: European Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
  • 4.4: APAC Infectious Disease Diagnostics Market
    • 4.4.1: APAC Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
    • 4.4.2: APAC Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR
  • 4.5: ROW Infectious Disease Diagnostics Market
    • 4.5.1: ROW Infectious Disease Diagnostics Market by Product: Reagents, Kits, and Consumables, Instruments, and Software & Services
    • 4.5.2: ROW Infectious Disease Diagnostics Market by Technology: Immunodiagnostics, NGS, INAAT, and PCR

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Product
    • 6.1.2: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Technology
    • 6.1.4: Growth Opportunities for the Global Infectious Disease Diagnostics Market by End Use
    • 6.1.5: Growth Opportunities for the Global Infectious Disease Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global Infectious Disease Diagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Infectious Disease Diagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Infectious Disease Diagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Thermo Fisher Scientific
  • 7.3: F. Hoffmann-La Roche
  • 7.4: bioMerieux
  • 7.5: Siemens Healthineers
  • 7.6: Danaher Corporation
  • 7.7: Becton and Dickinson